TY - JOUR
AU - Taylor, Kurt
AU - Eastwood, Sophie
AU - Walker, Venexia
AU - Cezard, Genevieve
AU - Knight, Rochelle
AU - Al Arab, Marwa
AU - Wei, Yinghui
AU - Horne, Elsie M.F.
AU - Teece, Lucy
AU - Forbes, Harriet
AU - Walker, Alex
AU - Fisher, Louis
AU - Massey, Jon
AU - Hopcroft, Lisa E.M.
AU - Palmer, Tom
AU - Cuitun Coronado, Jose Ignacio
AU - Ip, Samantha
AU - Davy, Simon
AU - Dillingham, Iain
AU - Morton, Caroline E.
AU - Greaves, Felix
AU - Macleod, John
AU - Goldacre, Ben
AU - Wood, Angela
AU - Chaturvedi, Nishi
AU - Sterne, Jonathan A.C.
AU - Denholm, Rachel
PY - 2024
DA - July
TI - Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people
JO - The Lancet Diabetes & Endocrinology
EP - 568
VL - 12
IS - 8
DO - https://doi.org/10.1016/S2213-8587(24)00159-1
AB - BackgroundSome studies have shown that the incidence of type 2 diabetes increases after a diagnosis of COVID-19, although the evidence is not conclusive. However, the effects of the COVID-19 vaccine on this association, or the effect on other diabetes subtypes, are not clear. We aimed to investigate the association between COVID-19 and incidence of type 2, type 1, gestational and non-specific diabetes, and the effect of COVID- 19vaccination, up to 52 weeks after diagnosis.
PB - Elsevier
UR - https://hdl.handle.net/2164/24207
KW - Coronavirus (COVID-19)
KW - Immunisation and screening
ER